1. Operating revenue for Q3FY22 was ₹18.3 million compared to ₹11.2 in Q2FY22.
2. Net loss for the Quarter was at ₹29.9 million mainly because of Esop.
3. Portfolio value of investments increased from ₹436.3 million on December 31, 2020 to ₹611.2 million on December 31, 2021.
Business Update
1. Signal Analytics, a wholly owned subsidiary raised ₹52.4 million by way of preferential allotment of Pre Series A. Thereby Xelpmoc shareholding in Signal has changed to 91.95% on a fully diluted basis.
2. During the quarter the company incorporated its wholly owned subsidiary Xelpmoc Design and Tech UK Limited for facilitating international expansion plans. 3. Xelpmoc also started their office in Hyderabad.
4. Company had some success in Uk and Us markets. Some of the projects are ongoing and these projects are onboarded in the recent past.
5. Their portfolio companies continue to grow.
6. Company continue to focus on the education sector with a multitude of opportunities that have arisen due to the Covid pandemic. They see some good growth opportunities in this space
7. Challenges around closing deals with new start-ups have decreased due to the pandemic situation.
8. Attrition rate was not high but there were some attrition.
Future Outlook.
1. Company expects traction in their service business from Q1FY22.
2. Company hopes and plans to see at least 8 to 10 clients per month and convert 1 or 2 depending upon the size of the projects for their service and start-up business.
2. Coming FY some of the start-ups will complete 7 years in their portfolio so the company will plan and discuss regarding selling their stake and cashing out.
3. Company currently has 3 products and they will re-look these products seriously and if they get a chance they will launch those in or after Q3FY23.
4. Company continue to look for startups to invest in. Mostly their focus is to invest in seed and pre-seed stage.
5. Company is also in talks with a VR,AR company.
6. Management expects sustainable green numbers in books from next Q3 onwards.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
1. For Q3FY22 revenue was ₹185.8 Cr vs ₹130.4 Cr in Q3FY21 a growth of 42% on YoY basis.
2. Q3 EBITDA was at ₹30.2 Cr as compared to ₹27.3 Cr in the same quarter of the previous year.
3. For 9M FY22 revenue was ₹446.6 Cr vs ₹330.8 Cr in 9MFY21 a growth of 35% on YoY basis.
4. 9MFY22 EBITDA surged by 141% to ₹79.7 Cr as compared to ₹33.1 Cr in 9MFY21.
5. Esports segment recorded revenue of ₹109.3 Cr in Q3FY22 vs ₹57.8 Cr last year in the same quarter, a growth of 89% YoY basis.
Their Gamified early learning segment recorded revenue of ₹47.2Cr.
1. Revenue for the quarter stood at ₹996.8 Cr (18% growth YoY).
2. EBITDA for the quarter was at ₹173 Cr (17.9% decline YoY).
3. EBITDA margins were at 17.4% compared to 25.1% in Q3 FY21.
4. They faced challenges during the quarter such as RM price increases, unstable supply from China and logistics issues. Their volumes were down compared to last year but they have been able to pass on a significant amount of price increases to their customers.
5. The overall gross margin recorded is lower due to change in segment mix in the total revenue. Share of Finished dosage has come down from 57% in Q2 to 46% in Q3 due to higher inventory build-up at USA and year end.